BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies Statistics

Total Valuation

BRTX has a market cap or net worth of $13.85 million. The enterprise value is $3.11 million.

Market Cap	13.85M
Enterprise Value	3.11M

Important Dates

The next confirmed earnings date is Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

BRTX has 7.50 million shares outstanding. The number of shares has increased by 84.05% in one year.

Current Share Class	7.50M
Shares Outstanding	7.50M
Shares Change (YoY)	+84.05%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	19.17%
Owned by Institutions (%)	3.88%
Float	4.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	35.72
Forward PS	6.12
PB Ratio	1.50
P/TBV Ratio	1.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	7.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.97

Current Ratio	2.97
Quick Ratio	2.91
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -96.89% and return on invested capital (ROIC) is -77.25%.

Return on Equity (ROE)	-96.89%
Return on Assets (ROA)	-58.03%
Return on Invested Capital (ROIC)	-77.25%
Return on Capital Employed (ROCE)	-135.44%
Revenue Per Employee	$36,455
Profits Per Employee	-$816,307
Employee Count	11
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +34.31% in the last 52 weeks. The beta is 77.48, so BRTX's price volatility has been higher than the market average.

Beta (5Y)	77.48
52-Week Price Change	+34.31%
50-Day Moving Average	1.73
200-Day Moving Average	1.70
Relative Strength Index (RSI)	56.05
Average Volume (20 Days)	23,254

Short Selling Information

The latest short interest is 172,692, so 2.30% of the outstanding shares have been sold short.

Short Interest	172,692
Short Previous Month	207,479
Short % of Shares Out	2.30%
Short % of Float	3.51%
Short Ratio (days to cover)	5.26

Income Statement

In the last 12 months, BRTX had revenue of $401,000 and -$8.98 million in losses. Loss per share was -$1.16.

Revenue	401,000
Gross Profit	372,928
Operating Income	-11.56M
Pretax Income	-6.96M
Net Income	-8.98M
EBITDA	-11.37M
EBIT	-11.56M
Loss Per Share	-$1.16

Balance Sheet

The company has $10.73 million in cash and n/a in debt, giving a net cash position of $10.73 million or $1.43 per share.

Cash & Cash Equivalents	10.73M
Total Debt	n/a
Net Cash	10.73M
Net Cash Per Share	$1.43
Equity (Book Value)	8.53M
Book Value Per Share	1.23
Working Capital	7.40M

Cash Flow

In the last 12 months, operating cash flow was -$8.23 million and capital expenditures -$106,189, giving a free cash flow of -$8.34 million.

Operating Cash Flow	-8.23M
Capital Expenditures	-106,189
Free Cash Flow	-8.34M
FCF Per Share	-$1.11

Margins

Gross Margin	93.00%
Operating Margin	-2,881.59%
Pretax Margin	-2,239.25%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-84.05%
Shareholder Yield	-84.05%
Earnings Yield	-64.85%
FCF Yield	-60.21%

Analyst Forecast

The average price target for BRTX is $18.00, which is 878.26% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.00
Price Target Difference	878.26%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	257.13%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on October 27, 2021. It was a reverse split with a ratio of 0.00025:1.

Last Split Date	Oct 27, 2021
Split Type	Reverse
Split Ratio	0.00025:1

Scores

BRTX has an Altman Z-Score of -18.49 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-18.49
Piotroski F-Score	2